Jeff Yass’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Jeff Yass's AMLX Position: Q3 2026 in Review
Jeff Yass increased its Amylyx Pharmaceuticals (AMLX) stake by 322% in Q3 2026, buying an estimated $883K and bringing the position to 43,651 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #7368.
Jeff Yass first reported a position in AMLX in Q1 2022 and has held it in 17 quarters since. The position peaked at $8.29M in Q4 2023. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Jeff Yass held 43,651 shares of Amylyx Pharmaceuticals worth $1.27M as of Q3 2026.
- Jeff Yass bought 33,312 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $883K.
- Amylyx Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7368 holding.
- Jeff Yass first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
- Jeff Yass's Amylyx Pharmaceuticals position peaked at $8.29M in Q4 2023.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.